Figure 5.
Figure 5. Effects of NGF and CGRP8-37 on B7 expression. A representative finding of 8 independent experiments showing CD80 and CD86 expression in peripheral-blood monocytes freshly taken (t0: A,G) or after 24 hours of different culture conditions: unstimulated cells (Us: B,H), LPS-treated monocytes (LPS: C,I) with or without the addition of anti-NGF antibody (LPS abNGF: D,J), control IgG (LPS IgG: E,K), CGRP8-37, the CGRP1 receptor antagonist (LPS CGRP8-37: F,L). Negative controls were cells incubated with isotype mouse IgG (darker area). For each population the values of ΔMFI for CD80 and CD86 positivity are included.

Effects of NGF and CGRP8-37 on B7 expression. A representative finding of 8 independent experiments showing CD80 and CD86 expression in peripheral-blood monocytes freshly taken (t0: A,G) or after 24 hours of different culture conditions: unstimulated cells (Us: B,H), LPS-treated monocytes (LPS: C,I) with or without the addition of anti-NGF antibody (LPS abNGF: D,J), control IgG (LPS IgG: E,K), CGRP8-37, the CGRP1 receptor antagonist (LPS CGRP8-37: F,L). Negative controls were cells incubated with isotype mouse IgG (darker area). For each population the values of ΔMFI for CD80 and CD86 positivity are included.

Close Modal

or Create an Account

Close Modal
Close Modal